Skip to main content
Top
Published in: International Cancer Conference Journal 2/2024

Open Access 03-02-2024 | Metastasis | Case report - Pathology

Intratumoral metastasis of sigmoid colon cancer to chromophobe renal cell carcinoma: a case report

Authors: Suzuna Sakai, Kojiro Ohba, Kazunari Migita, Ichiro Sekine, Yasuto Yamazaki

Published in: International Cancer Conference Journal | Issue 2/2024

Login to get access

Abstract

We herein report an extremely rare case of intratumoral metastasis of colon cancer to chromophobe renal cell carcinoma. A 71-year-old woman was diagnosed with lung metastasis of sigmoid colon cancer and underwent sigmoid colon resection with D3 lymph node dissection. Preoperative contrast-enhanced computed tomography (CT) revealed a left renal tumor; however, colon resection was prioritized, and the renal tumor was placed under observation. Two years later, CT revealed enlargement of the left renal tumor, and laparoscopic partial left nephrectomy was performed 1 month later. Histopathologic examination showed that the resected renal tumor was a chromophobe renal cell carcinoma with intratumoral metastasis of colon cancer to the renal tumor center, and adjuvant chemotherapy with bevacizumab plus SOX (L-OHP + S-1) was initiated. Because of severe chemotherapy-induced fatigue and nausea, the patient was switched to bevacizumab + S-1. However, the patient’s nausea did not improve after this change, and postoperative adjuvant chemotherapy was discontinued at the patient’s request 4 months after the partial nephrectomy. Two months after discontinuation of chemotherapy, CT showed no renal recurrence; however, increased lung metastases and a new bone metastasis in the left sciatic bone were observed. Palliative treatment was then initiated because of severe adverse events that made it difficult to continue treatment. In patients who have multiple cancers and an increase in renal tumor size, the possibility of intratumoral metastasis to the renal tumor should be considered.
Literature
2.
go back to reference Ottosson L, Berge T (1968) Metastasis from carcinoma to cartinoma. Acta Pathol Microbiol Scand 73:481–488CrossRefPubMed Ottosson L, Berge T (1968) Metastasis from carcinoma to cartinoma. Acta Pathol Microbiol Scand 73:481–488CrossRefPubMed
3.
go back to reference Ueno T, Asano K, Fujii S et al (2012) An autopsy case of multiple intra-cancerous metastasis to renal cell carcinoma. Nishi Nihon Urol 74:86–89 Ueno T, Asano K, Fujii S et al (2012) An autopsy case of multiple intra-cancerous metastasis to renal cell carcinoma. Nishi Nihon Urol 74:86–89
4.
go back to reference Yamaguchi K, Ogata Y, Daichi T et al (2011) A case of solitary renal metastasis from rectal cancer. J Jpn Surg Soc 44:1478–1484 Yamaguchi K, Ogata Y, Daichi T et al (2011) A case of solitary renal metastasis from rectal cancer. J Jpn Surg Soc 44:1478–1484
6.
go back to reference Ikenaga M, Kim HM, Hitora T et al (2014) A case of long-term survival in rectal cancer with late lung and kidney metastases treated with combined multimodality therapy. Gan To Kagaku Ryoho 41:1805–1807PubMed Ikenaga M, Kim HM, Hitora T et al (2014) A case of long-term survival in rectal cancer with late lung and kidney metastases treated with combined multimodality therapy. Gan To Kagaku Ryoho 41:1805–1807PubMed
7.
go back to reference Ortega P Jr, Li IY, Shimkin M (1951) Metastasis of neoplasms to other neoplasms. Ann West Med Surg 5:601–609PubMed Ortega P Jr, Li IY, Shimkin M (1951) Metastasis of neoplasms to other neoplasms. Ann West Med Surg 5:601–609PubMed
8.
go back to reference Chambers PW, Davis RL, Blanding JD et al (1980) Metastases to primary intracranial meningiomas and neurilemomas. Arch Pathol Lab Med 104:350–354PubMed Chambers PW, Davis RL, Blanding JD et al (1980) Metastases to primary intracranial meningiomas and neurilemomas. Arch Pathol Lab Med 104:350–354PubMed
9.
go back to reference Suwa K, Yoshida M, Shimizu S et al (2015) Tumor-to-tumor metasitasis from gastric cancer to a benign phyllodes tumor of the breast. Jpn J Breast Cancer 30:141–147 Suwa K, Yoshida M, Shimizu S et al (2015) Tumor-to-tumor metasitasis from gastric cancer to a benign phyllodes tumor of the breast. Jpn J Breast Cancer 30:141–147
10.
go back to reference Hibi H, Ito K, Ono K et al (1991) A case of metastatic lung cancer in renal cell carcinoma. J Urol 82:488–491 Hibi H, Ito K, Ono K et al (1991) A case of metastatic lung cancer in renal cell carcinoma. J Urol 82:488–491
11.
go back to reference Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572CrossRefPubMed Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572CrossRefPubMed
12.
go back to reference Paget S (1889) Distribution of secondary growth in cancer of the breast. Lancet 133:571–573CrossRef Paget S (1889) Distribution of secondary growth in cancer of the breast. Lancet 133:571–573CrossRef
13.
go back to reference Miiller A, Homey B, Soto H (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56ADSCrossRef Miiller A, Homey B, Soto H (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56ADSCrossRef
14.
go back to reference Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: A comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–853CrossRefPubMed Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: A comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–853CrossRefPubMed
Metadata
Title
Intratumoral metastasis of sigmoid colon cancer to chromophobe renal cell carcinoma: a case report
Authors
Suzuna Sakai
Kojiro Ohba
Kazunari Migita
Ichiro Sekine
Yasuto Yamazaki
Publication date
03-02-2024

Other articles of this Issue 2/2024

International Cancer Conference Journal 2/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine